Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,028,843 | 1,025,000 | -3,843 | $29.62M | $28.19M | 7.90% | -$1.43M |
| Acadia Healthcare Company, Inc.(ACHC) | 5,666 | 692,000 | +686,334 | $359.3K | $27.44M | 7.69% | +$27.08M |
| BridgeBio Pharma, Inc.(BBIO) | 1,086,810 | 995,000 | -91,810 | $27.67M | $27.30M | 7.65% | -$367.4K |
| MeiraGTx Holdings plc(MGTX) | 4,900,570 | 4,390,837 | -509,733 | $20.44M | $26.74M | 7.49% | +$6.30M |
| AbCellera Biologics Inc.(ABCL) | 9,079,539 | 7,350,000 | -1,729,539 | $23.61M | $21.54M | 6.03% | -$2.07M |
| ADC Therapeutics SASHS(ADCT) | 9,636,237 | 9,515,000 | -121,237 | $30.35M | $18.93M | 5.30% | -$11.42M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 465,825 | 451,127 | -14,698 | $18.17M | $18.65M | 5.23% | +$486.9K |
| ICON Public Limited CompanySHS(ICLR) | 0 | 85,000 | +85,000 | $0 | $17.83M | 4.99% | +$17.83M |
| Roivant Sciences Ltd.SHS(ROIV) | 1,721,512 | 1,500,000 | -221,512 | $19.87M | $17.75M | 4.97% | -$2.12M |
| Janux Therapeutics, Inc.(JANX) | 205,000 | 329,768 | +124,768 | $9.31M | $17.66M | 4.95% | +$8.34M |
| Schrödinger, Inc.(SDGR) | 700,000 | 720,500 | +20,500 | $12.98M | $13.90M | 3.89% | +$913.4K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 159,369 | 1,088,706 | +929,337 | $2.94M | $13.69M | 3.83% | +$10.74M |
| Zymeworks Inc.(ZYME) | 917,599 | 820,000 | -97,599 | $11.52M | $12.00M | 3.36% | +$488.9K |
| Kura Oncology, Inc.(KURA) | 705,109 | 1,325,000 | +619,891 | $13.78M | $11.54M | 3.23% | -$2.24M |
| Amicus Therapeutics Inc COM | 0 | 920,000 | +920,000 | $0 | $8.67M | 2.43% | +$8.67M |
| Zimmer Biomet Holdings, Inc.(ZBH) | 165,602 | 80,000 | -85,602 | $17.88M | $8.45M | 2.37% | -$9.43M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 554,103 | 620,000 | +65,897 | $10.67M | $8.20M | 2.30% | -$2.47M |
| Shattuck Labs, Inc.(STTK) | 5,678,726 | 6,638,935 | +960,209 | $19.82M | $8.03M | 2.25% | -$11.79M |
| Immunovant, Inc.(IMVT) | 370,000 | 305,523 | -64,477 | $10.55M | $7.57M | 2.12% | -$2.98M |
| Blueprint Medicines Corp | 47,100 | 67,000 | +19,900 | $4.36M | $5.84M | 1.64% | +$1.49M |
| Prothena Corp PlcSHS SHS | 483,467 | 418,122 | -65,345 | $8.09M | $5.79M | 1.62% | -$2.30M |
| CytomX Therapeutics, Inc.(CTMX) | 3,022,109 | 3,905,000 | +882,891 | $3.57M | $4.02M | 1.13% | +$456.1K |
| Haemonetics Corporation(HAE) | 65,000 | 46,700 | -18,300 | $5.22M | $3.65M | 1.02% | -$1.58M |
| Centene Corporation(CNC) | 0 | 55,000 | +55,000 | $0 | $3.33M | 0.93% | +$3.33M |
| Sight Sciences, Inc.(SGHT) | 531,222 | 908,847 | +377,625 | $3.35M | $3.31M | 0.93% | -$38.5K |
| LivaNova PLCSHS(LIVN) | 90,000 | 70,000 | -20,000 | $4.73M | $3.24M | 0.91% | -$1.49M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 130,000 | 270,000 | +140,000 | $2.68M | $3.19M | 0.89% | +$504.1K |
| Erasca, Inc.(ERAS) | 1,984,010 | 947,110 | -1,036,900 | $5.42M | $2.38M | 0.67% | -$3.04M |
| Spyre Therapeutics, Inc.(SYRE) | 0 | 80,000 | +80,000 | $0 | $1.86M | 0.52% | +$1.86M |
| CareDx, Inc.(CDNA) | 0 | 80,000 | +80,000 | $0 | $1.71M | 0.48% | +$1.71M |
| Mural Oncology Pub Ltd Co | 570,620 | 466,822 | -103,798 | $1.79M | $1.50M | 0.42% | -$282.9K |
| Fortrea Holdings Inc.(FTRE) | 0 | 55,100 | +55,100 | $0 | $1.03M | 0.29% | +$1.03M |
| Rein Therapeutics Inc.(RNTX) | 372,157 | 404,979 | +32,822 | $1.32M | $931.5K | 0.26% | -$386.0K |
| Immunome, Inc.(IMNM) | 39,135 | 54,342 | +15,207 | $572.2K | $577.1K | 0.16% | +$5.0K |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 63,754 | +63,754 | $0 | $548.3K | 0.15% | +$548.3K |
| Accolade Inc | 2,801,598 | 0 | -2,801,598 | $10.79M | $0 | — | -$10.79M |
| Cogent Biosciences, Inc.(COGT) | 410,830 | 0 | -410,830 | $4.44M | $0 | — | -$4.44M |
| Cytokinetics, Incorporated(CYTK) | 192,700 | 0 | -192,700 | $10.17M | $0 | — | -$10.17M |
| DexCom, Inc.(DXCM) | 160,000 | 0 | -160,000 | $10.73M | $0 | — | -$10.73M |
| Immuneering CorpCL A | 190,000 | 0 | -190,000 | $473.1K | $0 | — | -$473.1K |
| Maravai LifeSciences Holdings, Inc.CL A(MRVI) | 208,200 | 0 | -208,200 | $1.73M | $0 | — | -$1.73M |
| McKesson Corporation(MCK) | 35,822 | 0 | -35,822 | $17.71M | $0 | — | -$17.71M |
| Neurocrine Biosciences, Inc.(NBIX) | 62,000 | 0 | -62,000 | $7.14M | $0 | — | -$7.14M |
| Ovid Therapeutics Inc.(OVID) | 729,208 | 0 | -729,208 | $860.5K | $0 | — | -$860.5K |
| Select Med Hldgs Corp | 26,065 | 0 | -26,065 | $908.9K | $0 | — | -$908.9K |
| Tectonic Therapeutic, Inc.(TECX) | 137,614 | 0 | -137,614 | $4.17M | $0 | — | -$4.17M |
| Viking Therapeutics, Inc.(VKTX) | 48,000 | 0 | -48,000 | $3.04M | $0 | — | -$3.04M |
| Vincerx Pharma Inc | 2,206,505 | 0 | -2,206,505 | $1.58M | $0 | — | -$1.58M |